{"config":{"lang":["en"],"separator":"[\\s\\-]+","pipeline":["stopWordFilter"]},"docs":[{"location":"","title":"Welcome to the Research Archive of Casper M\u00f8ller Frederiksen, PhD","text":"<p>This site provides a comprehensive overview of the research contributions and publications by Casper M\u00f8ller Frederiksen. His work focuses on the intersection of hematology, data science, and molecular biology, aiming to improve patient outcomes through data-driven insights.</p>"},{"location":"#overview-of-research","title":"Overview of Research","text":"<p>[cite_start]Dr. Frederiksen's research portfolio is diverse, with a significant focus on data-driven hematology. [cite_start]His recent work involves creating large-scale data repositories for patients with lymphoid cancers to facilitate epidemiological, molecular, and data-driven research. [cite_start]This includes the application of machine learning and the development of medical artificial intelligence (mAI) to analyze complex datasets from nationwide registers and electronic health records.</p> <p>His earlier work spans several domains, including: * [cite_start]Infectious Diseases: Investigating virological responses to treatment in HIV patients, particularly focusing on co-infections and risk factors for treatment failure. * [cite_start]Molecular Biology: Identifying molecular phenotypes for bone marrow stromal cells and exploring the genetic basis of cancers through transcriptional profiling. * [cite_start]Oxidative Stress: Studying the effects of oxidative stress in astroglial cells.</p>"},{"location":"#quick-links","title":"Quick Links","text":"<ul> <li>About Me: Learn more about my professional background and affiliations.</li> <li>Publications: Browse a comprehensive list of my published work.</li> <li>Research Topics: Explore the key themes and projects of my research.</li> </ul>"},{"location":"about/","title":"About Casper M\u00f8ller Frederiksen, PhD","text":"<p>This page provides professional details for Casper M\u00f8ller Frederiksen.</p>"},{"location":"about/#professional-information","title":"Professional Information","text":"<ul> <li>[cite_start]Primary Affiliation: Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark.</li> <li>[cite_start]Additional Affiliation: Danish Cancer Institute, Copenhagen, Denmark.</li> <li>Past Affiliations:<ul> <li>[cite_start]Centre for Health and Infectious Disease Research (CHIP), Department of Infectious Diseases and Rheumatology, Rigshospitalet.</li> <li>[cite_start]Department of Endocrinology, Odense University Hospital, Odense C, Denmark.</li> <li>[cite_start]Molecular Diagnostic Laboratory, Department of Clinical Biochemistry, Aarhus University Hospital, Skejby, DK-8200 Aarhus N, Denmark.</li> <li>[cite_start]Department of Life Sciences and Chemistry, Roskilde University, 4000 Roskilde, Denmark.</li> </ul> </li> </ul>"},{"location":"about/#research-focus","title":"Research Focus","text":"<p>Dr. Frederiksen's work integrates clinical data and advanced computational methods to address complex medical challenges. His expertise includes: * [cite_start]Data-Driven Hematology  * [cite_start]Medical Artificial Intelligence (mAI)  * [cite_start]Large-Scale Clinical Databases  * [cite_start]HIV and Infectious Disease Epidemiology  * [cite_start]Genomic and Transcriptional Profiling  * [cite_start]Molecular Biology and Cellular Stress </p>"},{"location":"about/#competing-interests","title":"Competing Interests","text":"<ul> <li>[cite_start]Received funding from Octapharma during the conduct of the DALY-CARE study.</li> </ul>"},{"location":"publications/by_topic/","title":"Publications by Topic","text":"<p>This section categorizes publications based on their primary research theme.</p>"},{"location":"publications/by_topic/#hematology-and-data-driven-medicine","title":"Hematology and Data-Driven Medicine","text":"<ul> <li>Brieghel C, Werling M, Frederiksen CM, et al. (2025). The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology.<ul> <li>[cite_start]Summary: Details the creation and contents of the DALY-CARE data resource, a comprehensive national database for lymphoid cancer research in Denmark designed to foster epidemiological studies and the development of medical AI.</li> <li>DOI: 10.2147/CLEP.S479672</li> </ul> </li> </ul>"},{"location":"publications/by_topic/#infectious-diseases-hiv-cmv","title":"Infectious Diseases (HIV &amp; CMV)","text":"<ul> <li>Willemse S, Smit C, Sogni P, Frederiksen CM, et al. (2019). Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis.<ul> <li>DOI: 10.1111/jvh.13146</li> </ul> </li> <li>Monge S, Mocroft A, Sabin A, Frederiksen CM, et al. (2018). Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?<ul> <li>[cite_start]Summary: Evaluated disparities in cART response among migrant and native populations in Europe, finding variations based on origin and sex.</li> <li>DOI: 10.1111/hiv.12536</li> </ul> </li> <li>Judd A, Lodwick R, Noguera-Julian A, Frederiksen CM, et al. (2017). Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.<ul> <li>[cite_start]Summary: Identified higher rates and risk factors for triple-class virological failure in teenagers with perinatally acquired HIV.</li> <li>DOI: 10.1111/hiv.12411</li> </ul> </li> <li>De Luca A, Flandre P, Dunn D, Frederiksen CM, et al. (2016). Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.<ul> <li>[cite_start]Summary: Developed a new mutation score model that outperformed existing systems in predicting virological response to darunavir.</li> <li>DOI: 10.1093/jac/dkv465</li> </ul> </li> <li>Mocroft A, Lundgren J, Antinori A, Frederiksen CM, et al. (2015). Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.<ul> <li>[cite_start]Summary: Provided a cross-European update showing that late presentation for HIV care remains a significant issue.</li> <li>DOI: 10.2807/1560-7917.ES.2015.20.47.30070</li> </ul> </li> <li>Lodding IP, Sengel\u00f8v H, da Cunha-Bang C, Frederiksen CM, et al. (2015). Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections.<ul> <li>[cite_start]Summary: Found that CMV replication in transplant recipients is slower than often reported, suggesting that pre-emptive screening intervals can be extended.</li> <li>DOI: 10.1016/j.ebiom.2015.05.003</li> </ul> </li> <li>da Cunha-Bang C, Kirkby N, S\u00f8nderholm M, Frederiksen CM, et al. (2013). The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection.<ul> <li>[cite_start]Summary: Categorized ganciclovir-related mutations in CMV and showed that specific mutations are highly predictive of treatment failure.</li> <li>DOI: 10.1111/ajt.12042</li> </ul> </li> </ul>"},{"location":"publications/by_topic/#genomics-molecular-biology-cellular-stress","title":"Genomics, Molecular Biology &amp; Cellular Stress","text":"<ul> <li>Larsen KH, Frederiksen CM, Burns JS, et al. (2010). Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity.<ul> <li>[cite_start]Summary: Used DNA microarrays to identify a molecular signature in bone marrow stromal cells that predicts their ability to form bone in vivo.</li> <li>DOI: 10.1359/jbmr.091018</li> </ul> </li> <li>Frederiksen CM, H\u00f8jlund K, Hansen L, et al. (2008). Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes.<ul> <li>[cite_start]Summary: A study of myotubes from type 2 diabetes patients that found no primary defect in mitochondrial biogenesis genes, suggesting it is not an initial cause of insulin resistance.</li> <li>DOI: 10.1007/s00125-008-1122-9</li> </ul> </li> <li>MacKenzie ED, Selak MA, Tennant DA, Frederiksen CM, et al. (2007). Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells.<ul> <li>[cite_start]Summary: Designed and synthesized compounds to reverse the inhibition of HIF\u03b1 prolyl hydroxylase in cells with a dysfunctional TCA cycle, offering a potential cancer therapy strategy.</li> <li>DOI: 10.1128/MCB.01927-06</li> </ul> </li> <li>Frederiksen CM, Aaboe M, Dyrskj\u00f8t L, et al. (2003). Technical evaluation of cDNA microarrays.<ul> <li>[cite_start]Summary: A technical evaluation confirming the high quality and reproducibility of custom-produced cDNA microarrays.</li> <li>DOI: (Not provided in source)</li> </ul> </li> <li>Frederiksen CM, Knudsen S, Laurberg S, \u00d8rntoft TF. (2003). Classification of Dukes' B and C colorectal cancers using expression arrays.<ul> <li>[cite_start]Summary: Successfully used gene expression arrays to classify different stages of colorectal cancer, identifying key discriminating gene clusters.</li> <li>DOI: 10.1007/s00432-003-0434-x</li> </ul> </li> <li>Birkenkamp-Demtroder K, Christensen LL, Olesen SH, Frederiksen CM, et al. (2002). Gene expression in colorectal cancer.<ul> <li>[cite_start]Summary: An extensive gene expression profiling study of colorectal cancer that identified hundreds of relevant genes and potential therapeutic targets.</li> <li>DOI: (Not provided in source)</li> </ul> </li> <li>Thykjaer T, Workman C, Kruh\u00f8ffer M, Frederiksen CM, et al. (2001). Identification of gene expression patterns in superficial and invasive human bladder cancer.<ul> <li>[cite_start]Summary: Identified distinct gene expression patterns for different stages of bladder cancer, providing a basis for molecular classification.</li> <li>DOI: (Not provided in source)</li> </ul> </li> <li>Frederiksen CM, Clausen J. (1999). The effects of oxidative stress in in vitro cultured astroglial cells.<ul> <li>[cite_start]Summary: Investigated the metabolic transformation of paraquat in astroglial cells, showing it causes oxidative stress and dose-dependent DNA fragmentation.</li> <li>DOI: 10.1177/026119299902700307</li> </ul> </li> </ul>"},{"location":"publications/by_year/","title":"Publications by Year","text":""},{"location":"publications/by_year/#2025","title":"2025","text":"<ul> <li>Brieghel C, Werling M, Frederiksen CM, Parviz M, Lacoppidan T, Faitova T, Teglgaard RS, Vainer N, da Cunha-Bang C, Rotbain EC, Agius R, Niemann CU. The Danish Lymphoid Cancer Research (DALY-CARE) Data Resource: The Basis for Developing Data-Driven Hematology. Clin Epidemiol. [cite_start]2025 Feb 20;17:131-145. doi: 10.2147/CLEP.S479672.<ul> <li>Summary: This paper details the creation of DALY-CARE, a large-scale data repository for lymphoid cancer patients in Denmark. It combines data from 10 nationwide registers, electronic health records, and laboratory results to create a secure research environment for developing data-driven hematology, including medical AI tools.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2019","title":"2019","text":"<ul> <li>Willemse S, Smit C, Sogni P, Sarcletti M, Uberti-Foppa C, Wittkop L, Raben D, D'Arminio Monforte A, Dabis F, Van Der Valk M; Hepatocellular Carcinoma Screening Project Working Group for the Collaboration of Observational HIV on behalf of Epidemiological Research Europe (COHERE) In EuroCoord. Low compliance with hepatocellular carcinoma screening guidelines in hepatitis B/C virus co-infected HIV patients with cirrhosis. J Viral Hepat. [cite_start]2019 Oct;26(10):1224-1228. doi: 10.1111/jvh.13146.<ul> <li>(Note: Abstract not provided in source text. C.M. Frederiksen is listed as a collaborator). This study investigated adherence to screening guidelines for hepatocellular carcinoma in HIV patients co-infected with hepatitis B or C.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2018","title":"2018","text":"<ul> <li>Monge S, Mocroft A, Sabin A, Touloumi G, Sighem A, Abgrall S, Dray-Spira R, Spire B, Castagna A, Mussini C, Zangerle R, Hessamfar M, Anderson J, Hamouda O, Ehren K, Obel N, Kirk O, Antinori A, Girardi E, Saracino A, Calmy A, Wit S, Wittkop L, Bucher C, Montoliu A, Raben D, Prins M, Meyer L, Chene G, Burns F, Amo J; Migrant Health Working Group for the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord. Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all? HIV Med. [cite_start]2018 Jan;19(1):42-48. doi: 10.1111/hiv.12536.<ul> <li>Summary: This study evaluated differences in immunovirological response to cART between migrant and native populations in Western Europe. It found that response varies by geographical origin and sex, with migrants from sub-Saharan Africa starting treatment with lower CD4 counts and some groups experiencing lower virological response rates.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2017","title":"2017","text":"<ul> <li>Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, Garc\u00eda F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, F\u00e4tkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A; Pursuing Later Treatment Options II (PLATO II) Project Team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV Med. [cite_start]2017 Mar;18(3):171-180. doi: 10.1111/hiv.12411.<ul> <li>[cite_start]Summary: This study found that teenagers with perinatally acquired HIV have higher rates of triple-class virological failure compared to young adults infected heterosexually. [cite_start]Predictors for failure included being aged 10-14 at ART start, African origin, and NNRTI-based initial regimens.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2016","title":"2016","text":"<ul> <li>De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, G\u00fcnthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Sch\u00fclter E, Torti C, van Sighem A, Zangerle R, Descamps D; CHAIN and COHERE in EuroCoord. Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen. J Antimicrob Chemother. [cite_start]2016 May;71(5):1352-60. doi: 10.1093/jac/dkv465.<ul> <li>Summary: The study developed and validated a new weighted mutation score to predict virological response to darunavir in patients with HIV-1. This new model outperformed existing genotypic resistance interpretation systems for both B and non-B HIV subtypes.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2015","title":"2015","text":"<ul> <li>Mocroft A, Lundgren J, Antinori A, Monforte Ad, Br\u00e4nnstr\u00f6m J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D, De Wit S, F\u00e4tkenheuer G, Furrer H, Jadand C, Johnson A, Lazanas M, Leport C, Moreno S, Mussini C, Obel N, Post F, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Torti C, Warszawski J, Wittkop L, Zangerle R, Chene G, Raben D, Kirk O; Late presenters working group in COHERE in EuroCoord. Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013. Euro Surveill. [cite_start]2015;20(47). doi: 10.2807/1560-7917.ES.2015.20.47.30070.<ul> <li>[cite_start]Summary: An update on late presentation (LP) for HIV care across Europe from 2010-2013, showing that LP remains a significant issue with nearly half of individuals presenting with a CD4 count &lt;350/mm\u00b3 or an AIDS-defining event. [cite_start]The study calls for improved HIV testing strategies, especially for vulnerable groups.</li> </ul> </li> <li>Lodding IP, Sengel\u00f8v H, da Cunha-Bang C, Iversen M, Rasmussen A, Gustafsson F, Downing JG, Grarup J, Kirkby N, Frederiksen CM, Mocroft A, S\u00f8rensen SS, Lundgren JD; MATCH Programme Study Group. Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections. EBioMedicine. [cite_start]2015 Jul;2(7):699-705. doi: 10.1016/j.ebiom.2015.05.003.<ul> <li>Summary: This study re-evaluated the replication kinetics of CMV in transplant recipients, finding a median doubling time of 4.3 days, longer than previously reported. This suggests that screening intervals for pre-emptive therapy can be safely extended in cohorts with similar CMV doubling times.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2013","title":"2013","text":"<ul> <li>da Cunha-Bang C, Kirkby N, S\u00f8nderholm M, S\u00f8rensen SS, Sengel\u00f8v H, Iversen M, Rasmussen A, Gustafsson F, Frederiksen CM, Kjaer J, Lepri AC, Lundgren JD. The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection. Am J Transplant. [cite_start]2013 Feb;13(2):458-66. doi: 10.1111/ajt.12042.<ul> <li>[cite_start]Summary: This study investigated the clinical impact of ganciclovir-related mutations (GRMs) in the CMV-UL97 gene. [cite_start]It proposed a categorization of GRMs and found that \"Signature\" GRMs (sGRMs) were strongly associated with an excess risk of treatment failure, emerging after longer-term use of antiviral drugs.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2010","title":"2010","text":"<ul> <li>Larsen KH, Frederiksen CM, Burns JS, Abdallah BM, Kassem M. Identifying a molecular phenotype for bone marrow stromal cells with in vivo bone-forming capacity. J Bone Miner Res. [cite_start]2010 Apr;25(4):796-808. doi: 10.1359/jbmr.091018.<ul> <li>Summary: Using DNA microarrays, this study identified a molecular signature predictive of the in vivo bone-forming capacity of human bone marrow stromal cells (BMSCs). Cells with bone-forming potential had an overrepresentation of extracellular matrix genes, while non-bone-forming cells expressed more immune-response genes.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2008","title":"2008","text":"<ul> <li>Frederiksen CM, H\u00f8jlund K, Hansen L, Oakeley EJ, Hemmings B, Abdallah BM, Brusgaard K, Beck-Nielsen H, Gaster M. Transcriptional profiling of myotubes from patients with type 2 diabetes: no evidence for a primary defect in oxidative phosphorylation genes. Diabetologia. [cite_start]2008 Nov;51(11):2068-77. doi: 10.1007/s00125-008-1122-9.<ul> <li>[cite_start]Summary: This study examined gene expression in myotubes from patients with type 2 diabetes and found no evidence for differential expression of genes involved in mitochondrial oxidative metabolism. [cite_start]The results support the hypothesis that impaired mitochondrial biogenesis is not a primary, inherent defect leading to insulin resistance.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2007","title":"2007","text":"<ul> <li>MacKenzie ED, Selak MA, Tennant DA, Payne LJ, Crosby S, Frederiksen CM, Watson DG, Gottlieb E. Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol. [cite_start]2007 May;27(9):3282-9. doi: 10.1128/MCB.01927-06.<ul> <li>Summary: This research designed cell-permeating derivatives of alpha-ketoglutarate to counteract the \"pseudohypoxia\" induced by deficiencies in the TCA cycle enzymes SDH and FH. These derivatives successfully restored normal activity of HIF\u03b1 prolyl hydroxylase, suggesting a new therapeutic strategy for cancers associated with TCA cycle dysfunction.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2003","title":"2003","text":"<ul> <li>Frederiksen CM, Aaboe M, Dyrskj\u00f8t L, Laurberg S, Wolf H, \u00d8rntoft TF, Kruh\u00f8ffer M. Technical evaluation of cDNA microarrays. APMIS Suppl. [cite_start]2003;(109):96-101.<ul> <li>[cite_start]Summary: This study evaluated the technical performance of cDNA microarrays with a limited number of spots, concluding they are of high technical quality. [cite_start]It demonstrated that procedures for producing the arrays are reproducible and that LOWESS normalization is suitable for minimizing variation, even with high local background levels.</li> </ul> </li> <li>Frederiksen CM, Knudsen S, Laurberg S, \u00d8rntoft TF. Classification of Dukes' B and C colorectal cancers using expression arrays. J Cancer Res Clin Oncol. [cite_start]2003 May;129(5):263-71. doi: 10.1007/s00432-003-0434-x.<ul> <li>Summary: The study used gene expression microarrays to classify colorectal tumors, demonstrating that it is possible to classify Dukes' B and C samples with less than 20% error. Gene clusters related to mitochondrial function, stromal remodeling, and cell adhesion showed discriminating differences between the stages.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2002","title":"2002","text":"<ul> <li>Birkenkamp-Demtroder K, Christensen LL, Olesen SH, Frederiksen CM, Laiho P, Aaltonen LA, Laurberg S, S\u00f8rensen FB, Hagemann R, \u00d8rntoft TF. Gene expression in colorectal cancer. Cancer Res. [cite_start]2002 Aug 1;62(15):4352-63.<ul> <li>[cite_start]Summary: Using oligonucleotide microarrays, this research identified 226 known genes and 157 ESTs highly relevant for colorectal cancer (CRC). [cite_start]Cluster analysis grouped normal tissue with Dukes' A, and Dukes' B with C, while Dukes' D clustered separately, providing potential new tumor markers and therapeutic targets.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#2001","title":"2001","text":"<ul> <li>Thykjaer T, Workman C, Kruh\u00f8ffer M, Demtr\u00f6der K, Wolf H, Andersen LD, Frederiksen CM, Knudsen S, Orntoft TF. Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res. [cite_start]2001 Mar 15;61(6):2492-9.<ul> <li>Summary: This study used oligonucleotide arrays to establish gene expression patterns for superficial and invasive bladder tumors. Hierarchical clustering correctly identified the tumor stage and revealed stage-characteristic gene clusters related to cell proliferation, adhesion, and proteinases, offering new biological insights.</li> </ul> </li> </ul>"},{"location":"publications/by_year/#1999","title":"1999","text":"<ul> <li>Frederiksen CM, Clausen J. The effects of oxidative stress in in vitro cultured astroglial cells. Altern Lab Anim. [cite_start]1999 May-Jun;27(3):351-7. doi: 10.1177/026119299902700307.<ul> <li>[cite_start]Summary: This study showed that astroglial cells contain P450-reductase, which metabolizes paraquat, leading to the generation of free radicals and dose-dependent DNA fragmentation. [cite_start]The research also noted that DNA repair after exposure was slow, potentially due to the protracted generation of free radicals.</li> </ul> </li> </ul>"},{"location":"research/statistics/","title":"Research Statistics","text":"<p>This page presents a quantitative overview of Dr. Frederiksen's publication record based on the available data.</p>"},{"location":"research/statistics/#publication-count","title":"Publication Count","text":"<ul> <li>Total Publications (from provided list): 12<ul> <li>Note: This count is based on a specific PubMed export and may not be exhaustive.</li> </ul> </li> </ul>"},{"location":"research/topics/","title":"Research Topics","text":"<p>Dr. Frederiksen's research bridges clinical medicine with data science and molecular biology. The primary focus areas are detailed below.</p>"},{"location":"research/topics/#data-driven-hematology-and-medical-ai","title":"Data-Driven Hematology and Medical AI","text":"<p>[cite_start]A central theme of the current research is the development of \"data-driven hematology\". This involves leveraging large, nationwide health datasets to advance the understanding and treatment of hematological cancers. [cite_start]The goal is to create a framework where meta-learning and medical artificial intelligence (mAI) can be applied to complex patient data, a field that has been limited by the lack of large, shared datasets. [cite_start]By creating open-source processing pipelines and a secure cloud-computing environment, this research aims to build tools that can be deployed directly into EHR systems, providing near real-time decision support for clinicians.</p>"},{"location":"research/topics/#cancer-genomics-and-molecular-classification","title":"Cancer Genomics and Molecular Classification","text":"<p>Early work focused on using microarray technology to understand the molecular basis of cancer. This involved large-scale gene expression profiling to: * [cite_start]Classify Tumors: Differentiate between stages of colorectal and bladder cancer based on unique transcriptional signatures. [cite_start]This work demonstrated that molecular classification of common cancers was becoming a reality. * [cite_start]Identify Biomarkers: Pinpoint new potential tumor markers and therapeutic targets by identifying genes that are consistently up- or down-regulated in tumor tissue compared to normal tissue. [cite_start]A key finding was the consistent down-regulation of 15 nuclear-encoded mitochondrial proteins in colorectal cancer.</p>"},{"location":"research/topics/#infectious-disease-epidemiology-in-vulnerable-populations","title":"Infectious Disease Epidemiology in Vulnerable Populations","text":"<p>[cite_start]As a collaborator in large European cohorts like COHERE, Dr. Frederiksen contributed to major studies on HIV and other viral infections. This research has explored: * [cite_start]Treatment Response Disparities: Investigating why immunological and virological responses to antiretroviral therapy differ between migrant and native populations in Europe. * [cite_start]Virological Failure: Identifying risk factors for treatment failure in specific populations, such as teenagers with perinatally acquired HIV. * [cite_start]Viral Resistance: Developing improved methods for predicting viral resistance to specific drugs, such as darunavir, and understanding the clinical impact of resistance mutations in CMV infections post-transplant.</p>"},{"location":"research/topics/#cellular-stress-and-metabolism","title":"Cellular Stress and Metabolism","text":"<p>Research at the cellular level has investigated fundamental biological processes and their role in disease. This includes: * [cite_start]Metabolic Dysfunction in Disease: Studying the link between TCA cycle dysfunction, \"pseudohypoxia,\" and cancer, leading to the design of novel therapeutic compounds. * [cite_start]Primary Defects in Type 2 Diabetes: Using transcriptional profiling to test the hypothesis that impaired mitochondrial biogenesis is a primary, inherited defect in type 2 diabetes, with findings suggesting it is not. * [cite_start]Oxidative Stress: Examining how xenobiotics can induce oxidative stress and DNA damage in astroglial cells, providing insight into the cellular effects of free radicals.</p>"}]}